Drug Type Small molecule drug |
Synonyms |
Mechanism Cytokine receptors antagonists, MMPs inhibitors(Matrix metalloproteinase inhibitors), Protease inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC19H18N2O7 |
InChIKeyLNWJCWHPBFSTHP-AQRPAEKGSA-N |
CAS Registry263258-27-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anthrax | Discovery | US | - |